Genta Just Won’t Give Up on Genasense
Make a commentBy Ed Silverman // February 6th, 2007 // 9:20 am
The struggling little company this morning issued a statement saying it will appeal a recent FDA decision rejecting approval of its Genasense cancer drug.
The agency issued a non-approvable notice two months ago. In simple English, this means ‘fuggehdabotit.’ To convince the agency, Genta will have to start a new clinical trial.
Genta wants Genasense approved for use with chemotherapy in patients with chronic lymphocytic leukemia, a type of blood cancer. The company will file its appeal by the end of March.
[tags]Genta[/tags]